Horizon Pharma (HZNP) PT Raised to $20 at Piper Jaffray
Tweet
Share
E-mail
Get Alerts HZNP Hot Sheet
Price: $116.30 --0%
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Piper Jaffray raised its price target on Horizon Pharma (NASDAQ: HZNP) to $20.00 (from $18.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CACI International (CACI) PT Raised to $440 at Stifel
- Premier Financial Corp. (PFC) PT Raised to $22 at Piper Sandler
- Symrise AG (SY1:GR) (SYIEY) PT Raised to EUR120 at CFRA
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
